Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia

Abstract Introduction Plasma phosphorylated tau (p‐tau)217 is a leading blood‐biomarker for the detection of amyloid beta (Aβ) pathology. We assessed the performance of a fully automated plasma p‐tau217 immunoassay to detect Aβ pathology in mild cognitive impairment (MCI)/mild dementia. Methods Pair...

Full description

Saved in:
Bibliographic Details
Main Authors: Adam H. Dyer, Jean Dunne, Helena Dolphin, Laura Morrison, Antoinette O'Connor, Sarah Fullam, Tara Kenny, Aoife Fallon, Sean O'Dowd, Nollaig M. Bourke, Niall P. Conlon, Sean P. Kennelly, for the TIMC‐BRAiN Study Group
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Alzheimer's disease
amyloid
biomarker
cerebrospinal fluid
plasma
tau
Online Access:https://doi.org/10.1002/dad2.70080
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/dad2.70080

Similar Items